Open AccessFourteen-vsseven-day bismuth-based quadruple therapy for second-lineHelicobacter pylorieradication
Author(s) -
Jae Jin Hwang
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i26.8132
Subject(s) - helicobacter pylori , medicine , metronidazole , gastroenterology , urea breath test , rabeprazole , intention to treat analysis , esomeprazole , breath test , proton pump inhibitor , surgery , helicobacter pylori infection , adverse effect , antibiotics , microbiology and biotechnology , biology
To compare the efficacy of 14- and 7-d bismuth-based quadruple therapies as second-line eradication treatment for Helicobacter pylori (H. pylori) infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom